All Posts By

IDEAYA Biosciences

IDEAYA Biosciences Appoints Paul Stone, J.D., as Senior Vice President and General Counsel, Head of Operations and Mark Lackner, Ph.D., as Vice President, Head of Biomarkers and Synthetic Lethal Biology

By Press Release
IDEAYA Biosciences, Inc., an oncology-focused biotechnology company committed to the discovery of breakthrough synthetic lethality medicines and immuno-oncology therapies, announced today the appointment of Paul Stone, J.D., as senior vice...
Read More